Journal for ImmunoTherapy of Cancer (Nov 2021)

548 Phase 2 study of FLX475 in combination with ipilimumab in advanced melanoma

William Ho,
Rakesh Goyal,
Nicole Nasrah,
Dan Johnson

Affiliations

William Ho: 10RAPT Therapeutics, South San Francisco, CA, USA
Rakesh Goyal: RAPT Therapeutics, South San Francisco, CA, USA
Nicole Nasrah: RAPT Therapeutics, South San Francisco, CA, USA
Dan Johnson: RAPT Therapeutics, South San Francisco, CA, USA

DOI: https://doi.org/10.1136/jitc-2021-SITC2021.548
Journal volume & issue: Vol. 9, no. Suppl 2

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal